跳至正文
研究论文

Remnant Cholesterol, C-Reactive Protein, and Risks of Lung Cancer Morbidity and Mortality Among Women: A Prospective Cohort Study.

Qie Ranran, Liu Hongwei, Liu Yin, Guo Xiaoli, Chen Qiong, Xu Huifang, Wang Xiaoyang, Wang Hong, Kang Ruihua, Cheng Cheng, Zhao Mengfei, Zheng Liyang, Liu Shuzheng, Zhang Shaokai · 共同作者

American journal of preventive medicine2026; 70(1): 108140

DOI
10.1016/j.amepre.2025.108140
PMID
41067549

摘要

INTRODUCTION: Previous studies have highlighted the importance of blood lipid levels in lung cancer. However, evidence of the association between remnant cholesterol and lung cancer remains scarce. This study aimed to investigate the association of remnant cholesterol with lung cancer morbidity and mortality and to evaluate their joint effects with C-reactive protein in women.

Methods

This prospective cohort study included 198,154 women initially without cancer from the UK Biobank. Remnant cholesterol was calculated as non-high-density lipoprotein cholesterol minus the measured low-density lipoprotein cholesterol. Cox models were adopted to estimate hazard ratios and 95% CIs for the incidence of lung cancer. Data were collected between 2006 and 2022 and analyzed in 2025.

Results

During a median follow-up of 11.80-13.90 years, 1,552 lung cancer cases and 1,074 related deaths were identified. Remnant cholesterol was positively associated with lung cancer morbidity and mortality in a linear manner, with respective hazard ratios (95% CIs) of 1.50 (1.23, 1.82) and 1.40 (1.11, 1.77) in Quartile 4. Compared with the low remnant cholesterol/low C-reactive protein group, the risk of incident lung cancer and lung cancer mortality increased by 115% and 102%, respectively, in the high remnant cholesterol/high C-reactive protein group. The cumulative risks of lung cancer by age 80 years were higher in the high remnant cholesterol/high C-reactive protein group than in the low remnant cholesterol/low C-reactive protein group (morbidity=3.64% vs 1.56%; mortality=1.97% vs 0.82%).

Conclusions

This study found linear and positive associations of remnant cholesterol with lung cancer morbidity and mortality among women. The combination of high remnant cholesterol and C-reactive protein conferred the highest relative and absolute risks. These findings highlighted the importance of considering the combination of remnant cholesterol and C-reactive protein levels for the primary prevention of lung cancer and selection of high-risk populations for lung cancer screening among women.

陈琼发布于 319 字约 2 分钟阅读浏览量加载中…

留言板

欢迎留下与本页内容相关的问题、建议或想法。

正在读取留言…

审核通过后,昵称和留言将公开显示。请勿填写私人联系方式。

← 返回论文列表